BioCardia (BCDA) Total Liabilities (2010 - 2026)

BioCardia (BCDA) has reported Total Liabilities for 16 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities fell 48.3% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $2.1 million, a 48.3% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 12.78% from the prior year.
• Total Liabilities was $2.1 million for Q2 2026 at BioCardia, down from $2.8 million in the prior quarter.
• Over five years, Total Liabilities peaked at $5.5 million in Q1 2022 and troughed at $2.1 million in Q2 2026.
• A 5-year average of $4.1 million and a median of $4.5 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities advanced 29.71% in 2022 and slumped 48.3% in 2026, its largest moves.
• Over 5 years, Total Liabilities stood at $4.9 million in 2022, then fell by 6.35% to $4.6 million in 2023, then slumped by 37.1% to $2.9 million in 2024, then dropped by 12.78% to $2.5 million in 2025, then decreased by 18.39% to $2.1 million in 2026.
• The last three Total Liabilities figures came in at $2.1 million (Q2 2026), $2.8 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.